Cellectis (CLLS) Enterprise Value (2016 - 2023)
Historic Enterprise Value for Cellectis (CLLS) over the last 11 years, with Q3 2023 value amounting to -$93.2 million.
- Cellectis' Enterprise Value rose 5292.69% to -$93.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$93.2 million, marking a year-over-year increase of 5292.69%. This contributed to the annual value of -$96.5 million for FY2022, which is 98471.13% down from last year.
- Latest data reveals that Cellectis reported Enterprise Value of -$93.2 million as of Q3 2023, which was up 5292.69% from -$94.3 million recorded in Q2 2023.
- In the past 5 years, Cellectis' Enterprise Value ranged from a high of $10.9 million in Q4 2021 and a low of -$410.6 million during Q2 2019
- In the last 5 years, Cellectis' Enterprise Value had a median value of -$217.4 million in 2021 and averaged -$197.1 million.
- As far as peak fluctuations go, Cellectis' Enterprise Value soared by 10448.62% in 2021, and later tumbled by 98398.72% in 2022.
- Over the past 5 years, Cellectis' Enterprise Value (Quarter) stood at -$347.8 million in 2019, then skyrocketed by 30.08% to -$243.2 million in 2020, then surged by 104.49% to $10.9 million in 2021, then tumbled by 983.99% to -$96.4 million in 2022, then grew by 3.35% to -$93.2 million in 2023.
- Its Enterprise Value was -$93.2 million in Q3 2023, compared to -$94.3 million in Q2 2023 and -$81.4 million in Q1 2023.